These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7327921)

  • 1. Effect of pindolol on blood parathyroid hormone concentration.
    Shasha SM; Ben Aryeh H; Shiller M; Bernheim J
    Isr J Med Sci; 1981 Dec; 17(12):1189-90. PubMed ID: 7327921
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of essential hypertension with pindolol].
    Kocemba J; Kawecka-Jaszcz K; Sniezek M; Starzycka M; Augustyński W
    Kardiol Pol; 1978; 21(3):201-8. PubMed ID: 691928
    [No Abstract]   [Full Text] [Related]  

  • 3. [M-mode echocardiographic evaluation of antihypertensive efficacy and the mechanism of action of pindolol].
    Bissoli GS; La Canna G; Zanini R; Caobelli A; Berra P; Ettori F; Arosio G
    Minerva Cardioangiol; 1985 Jun; 33(6):337-43. PubMed ID: 4047421
    [No Abstract]   [Full Text] [Related]  

  • 4. [Long-term treatment of essential hypertension using a beta-receptor blockader: effect on total-body-potassium and exchangeable sodium].
    Brecht HM; Werner E; Vlachoyannis J; Bechstein PB; Schoeppe W
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1329-32. PubMed ID: 1029992
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of essential hypertension with prindolol].
    Kuska J; Sledzinski Z; Kokot F
    Wiad Lek; 1977 Apr; 30(7):505-10. PubMed ID: 855327
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of beta-adrenergic block with pindolol on the haemodynamics, oxygen consumption and pH of blood of the hypertensive patient during submaximum effort (author's transl)].
    Chrástek J; Kavánková M; Boudová L; Zenísek A; Matousek O
    Cas Lek Cesk; 1973 Sep; 112(39):1209-12. PubMed ID: 4744776
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of the combination of Pindolol and clopamide in systemic arterial hypertension. A multicenter study].
    Zilenovski AM; Freire CA
    Arq Bras Cardiol; 1981 Sep; 37(3):219-24. PubMed ID: 7052028
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of treatment with propranolol or pindolol on the left ventricular myocardium mass in patients with slight essential arterial hypertension].
    Haczyński J; Spring A
    Wiad Lek; 1993 Apr; 46(7-8):241-4. PubMed ID: 8249408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary composition in patients with essential hypertension and the effect of Pindolol.
    Ben-Aryeh H; Schiller M; Shasha S; Szargel R; Gutman D
    J Oral Med; 1981; 36(3):76-8. PubMed ID: 6945404
    [No Abstract]   [Full Text] [Related]  

  • 10. Experience with pindolol in African hypertensives.
    Abdullah MS
    East Afr Med J; 1983 Dec; 60(12):833-7. PubMed ID: 6676093
    [No Abstract]   [Full Text] [Related]  

  • 11. [Haemodynamic effect of short-term adrenergic block with prindolol at rest and during strain in hypertonic subjects (stage II)].
    Ressl J; Chrástek J; Jandová R; Nhon TQ
    Cas Lek Cesk; 1974 Oct; 113(43):1317-21. PubMed ID: 4429976
    [No Abstract]   [Full Text] [Related]  

  • 12. [Carteolol in essential hypertension. Dose range study and controlled open trial in comparison with pindolol].
    Werning C
    Arzneimittelforschung; 1983; 33(2a):325-30. PubMed ID: 6682324
    [No Abstract]   [Full Text] [Related]  

  • 13. Viskaldix in the treatment of essential hypertension. A study on hospital out-patients.
    Cameron EG; Crowder D
    Practitioner; 1981 Apr; 225(1354):581-5. PubMed ID: 7279846
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulation of parathyroid hormone and vitamin D in essential hypertension.
    Young EW; Morris CD; Holcomb S; McMillan G; McCarron DA
    Am J Hypertens; 1995 Oct; 8(10 Pt 1):957-64. PubMed ID: 8845076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long term study (1 year) with a beta receptor blocker-diuretic combination in hypertension treatment].
    Gotzen R; Faupel RP; Hammerschmidt D
    Med Welt; 1981 Sep; 32(39):1450-2. PubMed ID: 7029197
    [No Abstract]   [Full Text] [Related]  

  • 16. A beta blocker-thiazide combination in the treatment of hypertension in diabetics.
    Chazan BI; Old JM; Venkataraman G; Snape J; Cameron EG
    Br J Clin Pract; 1981; 35(11-12):393-8. PubMed ID: 7030375
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of effect of calcium carbonate supplementation on 24h blood pressure, angiotensin II reactivity and PTH(1-84) in essential hypertension.
    Jespersen B; Brock A; Pedersen EB
    J Hum Hypertens; 1993 Feb; 7(1):103-4. PubMed ID: 8450513
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of pindolol and milnacipran versus milnacipran and placebo on plasma prolactin and adrenocorticotrophic hormone in depressed subjects.
    Isaac MB; Isaac MT
    Hum Psychopharmacol; 2003 Oct; 18(7):569-74. PubMed ID: 14533141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure reactivity in the evaluation of resting blood pressure and mood responses to pindolol and propranolol in hypertensive patients.
    Potempa KM; Fogg LF; Fish AF; Kravitz HM
    Heart Lung; 1993; 22(5):383-91. PubMed ID: 8226001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of blood purification on plasma levels of intact parathyroid hormone in patients with chronic renal failure.
    Liu J; Liu ZQ; Tao HQ
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Feb; 24(2):234-5. PubMed ID: 14965840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.